Delivery Order SPE2DB22D3016-SPE2DB24FBDX5

Award Date 8/13/24
Potential Completion Date 9/4/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,714.98 order is for 4,563,358,879 units of the pharmaceutical product INGREZZA 80 MG CAPSULE 30S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S. government agencies,...
This is a $4,027.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
This is a $29,785.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 80 mg capsules of the pharmaceutical drug INGREZZA. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen is a major pharmaceutical distributor to the federal government and holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice for the provision of a wide range of...
This is a $3,676.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 40 MG CAPSULE 30S, a prescription medication, with a performance period through July 23, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $14,213.24 to AmerisourceBergen Drug Corp for the supply of 4,563,906,336 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). This contract is a task order under a larger...
This is a $22,056.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $7,828.66 and a period of performance through August 21, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of its extensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $11,679.45 contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $14,213.24 firm fixed price delivery order for 4,564,804,576 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of June 26, 2024 and was awarded on June 4, 2024 by the Defense Logistics Agency (DLA), a defense agency. The award is associated with Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $7,352.24 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of INGREZZA 40 MG CAPSULE 30S. The ultimate completion date is June 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides comprehensive global pharmaceutical support to military healthcare...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBDX5
    Delivery Order

This is a $11,742.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,442,072 units of the prescription drug INGREZZA 60 mg capsules. The award has an ultimate completion date of September 4, 2024 and does not have a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with the DLA and other federal agencies for providing a wide range of medical commodities, including prescription drugs, medical supplies, and equipment to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 11/12/24, 9:13 AM